Natural products derived from traditional medicines are valuable sources of potential geroprotective compounds; however, their translation into therapeutic candidates is limited by chemical complexity, polypharmacology, limited mechanistic resolution, and lengthy experimental validation. Artificial intelligence (AI) offers an emerging framework for integrating chemical, pharmacological, multi-omics, imaging, and literature derived data to accelerate natural product anti-aging research. This review summarizes recent applications of AI in three interconnected areas: drug repurposing, prediction of aging-related targets and signaling pathways, and identification of biomarkers for biological aging and cellular senescence. AI integrates chemical, molecular, omics, and imaging data to prioritize candidate compounds, predict drug-target interactions, identify synergistic combinations, and reveal mechanisms underlying geroprotection. However, computational predictions should not be interpreted as evidence of efficacy or causality. Data heterogeneity, sampling bias, limited model interpretability, inadequate external validation, and insufficient pharmacokinetic and long-term safety assessment remain major barriers to translation. Future progress will require an iterative framework that combines AI prediction with target engagement studies, senescence models, organoids, animal experiments, and clinical biomarker validation. This integrated strategy may improve the efficiency, reproducibility, and translational potential of natural product geroscience research.
Zhao, et al. “Artificial intelligence-assisted discovery of natural product geroprotectors: target prediction, aging biomarker identification, and drug repurposing.” Biogerontology, 2026. doi:10.1007/s10522-026-10543-9.
@article{Zhao2026,
title = {Artificial intelligence-assisted discovery of natural product geroprotectors: target prediction, aging biomarker identification, and drug repurposing},
author = {Zhao and Yiru and Li and Mei and Liu and Jinglun and Xu and Binyu and Luo and Wei and Peng and Yongjun and Yang and Lijiao and Tan and Rui and Jiang and Hezhong},
journal = {Biogerontology},
year = {2026},
doi = {10.1007/s10522-026-10543-9},
url = {http://link.springer.com/openurl/fulltext?id=doi:10.1007/s10522-026-10543-9}
}
Extreme longevity is accompanied by cardiac molecular remodelling, yet the basis of sex-associated adaptation during late-life aging remains incompletely understood. Here, we performed cardiac proteomic and multi-compartment metabolomic...
Aging induces structural and functional alterations in the skin, characterized by diminished collagen synthesis and impaired cellular turnover, resulting in progressive thinning and reduced elasticity. The incorporation of plant-derived...
Replicative senescence links telomere shortening to irreversible proliferative arrest and is widely recognized as a major tumor-suppressive mechanism. At the organismal level, however, progressive accumulation of senescent cells...
Vascular endothelial cell (VEC) senescence is a key contributor to vascular aging and atherosclerosis. Increasing evidence suggests that long non-coding RNAs (lncRNAs) can encode functional micropeptides involved in cellular regulation....
Aging is accompanied by alterations in inflammatory signaling, regulated cell-death pathways, and cellular stress responses in the brain. This study investigated the effects of propolis and dexpanthenol, administered individually or in...